Philippines Mulls Price-Control Of Additional ‘Essential’ Cancer Drugs
This article was originally published in PharmAsia News
Executive Summary
The Philippines is considering additional cancer drugs to be subjected to price controls aimed at lowering the cost of drugs considered “essential.”